CIK 0001021561
- Accelerated filer
NU SKIN ENTERPRISES, INC.
Sign in to watch- Ticker
- NUS
- Exchange
- NYSE
- Industry
- Wholesale-Drugs, Proprietaries & Druggists' Sundries
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 870565309
- Phone
- +1 801-345-1000
- Business address
- 75 WEST CENTER ST, ATTN: GREGORY BELLISTON, PROVO, UT, 84601
- Former names
- NU SKIN ENTERPRISES INC, NU SKIN ASIA PACIFIC INC, NU SKIN ASIA INC
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2022-05-25 | NAPIERSKI RYAN S President and CEO | Sale | −9,452 | $44.55 | $421K | 138,231 |
| 2022-05-25 | NAPIERSKI RYAN S President and CEO | Sale | −15,548 | $45.13 | $702K | 122,683 |
| 2022-05-25 | NAPIERSKI RYAN S President and CEO | Exercise or conversion · Employee Stock Option (Right to Buy) | −13,000 | 25,000 | ||
| 2022-05-25 | NAPIERSKI RYAN S President and CEO | Exercise or conversion · Employee Stock Option (Right to Buy) | −12,000 | 44,000 | ||
| 2022-05-23 | LIPMAN ANDREW D Director | Sale | −1,000 | $44.95 | $45K | 70,214 |
| 2022-05-18 | LUND STEVEN Exec. Chairman of the Board | Sale | −925 | $46.07 | $43K | 179,449 |
| 2022-05-16 | LUND STEVEN Exec. Chairman of the Board | Sale | −21,200 | $45.25 | $959K | 180,374 |
| 2022-05-13 | LUND STEVEN Exec. Chairman of the Board | Gift | −14,010 | 202,499 | ||
| 2022-05-13 | LUND STEVEN Exec. Chairman of the Board | Gift | −14,935 | 201,574 | ||
| 2022-04-22 | LIPMAN ANDREW D Director | Sale | −1,000 | $47.72 | $48K | 71,214 |
| 2022-04-21 | Tang Connie Mang Yee Chief Global Growth Officer | Grant or award | +5,264 | 32,807 | ||
| 2022-04-21 | Tang Connie Mang Yee Chief Global Growth Officer | Shares withheld for taxes | −1,120 | $47.50 | $53K | 31,687 |
| 2022-03-22 | LIPMAN ANDREW D Director | Sale | −1,000 | $47.40 | $47K | 72,214 |
| 2022-03-09 | WOODBURY EDWINA D Director | Grant or award | +12 | $47.90 | $575 | 13,488 |
| 2022-03-02 | CHANG JOSEPH Y Chief Scientific Officer | Exercise or conversion | +3,423 | $30.63 | $105K | 26,380 |
| 2022-03-02 | CHANG JOSEPH Y Chief Scientific Officer | Sale | −2,500 | $45.86 | $115K | 23,880 |
| 2022-03-02 | CHANG JOSEPH Y Chief Scientific Officer | Sale | −923 | $46.53 | $43K | 22,957 |
| 2022-03-02 | CHANG JOSEPH Y Chief Scientific Officer | Exercise or conversion · Employee Stock Option (Right to Buy) | −3,423 | 42,600 | ||
| 2022-03-01 | CHANG JOSEPH Y Chief Scientific Officer | Exercise or conversion | +28,577 | $30.63 | $875K | 51,534 |
| 2022-03-01 | CHANG JOSEPH Y Chief Scientific Officer | Sale | −28,280 | $45.21 | $1.3M | 23,254 |
Page 14 of 15 · 288 trades